Pennsylvania adults can access gender-affirming care in 2026 without any state-level restriction. Pennsylvania has not enacted a law banning care for any age group, and Pennsylvania Medical Assistance has covered medically necessary gender transition services since the state removed its exclusion in 2016. Access for patients under 19 is a different story in 2026. Federal Executive Order 14187, signed January 28, 2025, pushed several systems to retreat: Penn Medicine stopped gender-affirming surgery for patients under 19 in May 2025, and UPMC ended its youth programs in June 2025 before agreeing on September 18, 2026 to a $950,000 federal settlement that includes ending such care for patients under 19. The Children's Hospital of Philadelphia has continued its program but remains under federal scrutiny. Adult care at Penn Medicine, Philadelphia's Mazzoni Center, Planned Parenthood clinics, and telehealth platforms remains available across Pennsylvania.
Pennsylvania Medical Assistance (Medicaid), administered by the Department of Human Services (DHS) and delivered mostly through HealthChoices managed care plans, requires plans to decide medical necessity for gender dysphoria treatment using the most recent World Professional Association for Transgender Health standards. Covered services can include psychotherapy, hormone therapy, laboratory monitoring, and surgeries such as breast augmentation, chest reconstruction, orchiectomy, hysterectomy, vaginoplasty, and phalloplasty, each subject to prior authorization by the member's plan. A federal final rule published in August 2026 and effective in October 2026 bars federal Medicaid and CHIP matching funds for puberty suppression, hormones, and surgery for minors (under 18 in Medicaid, under 19 in CHIP), with a tapering period of up to 6 months for existing hormone therapy (KFF 2026). States may still use state-only dollars. Senate Bill 1321, which would align Pennsylvania with the federal restriction, cleared a Senate committee on May 6, 2026 and was not law as of October 2026.
Pennsylvania readers will find in this guide what gender-affirming care costs in Pennsylvania in 2026 for self-pay and insured adults, what Original Medicare covers, how to get a written Good Faith Estimate from any Pennsylvania provider, and which self-pay discounts apply. The KFF Gender-Affirming Care Policy Tracker at kff.org/lgbtq/gender-affirming-care-policy-tracker/ follows federal and state changes. Patients who may qualify for Medical Assistance or sliding-scale clinics can check Medicaid income limits and the federal poverty level. Patients holding a bill from care already received can run it through the medical bill analyzer to find errors and next steps. Gender-affirming care is not a USPSTF preventive service, so standard deductible and cost-sharing rules apply under most plans.
Gender-Affirming Care (Pennsylvania) Cost by Site of Service in 2026
The biggest cost driver of Gender-Affirming Care (Pennsylvania) is the site of service: where the procedure is performed. 2026 CMS price transparency data confirms a 2-3x billing differential between independent centers and hospital outpatient departments.
Gender-Affirming Care (Pennsylvania) prices without insurance vs. 2026 Medicare rates| Site of Service | Range Without Insurance | 2026 Medicare Rate |
|---|
| Telehealth platform (FOLX Health, Plume, informed-consent HRT services serving Pennsylvania) | $30 to $150 per month (HRT only) | Part D covers qualifying hormones; telehealth visits may qualify under Part B |
| FQHC or sliding-scale clinic (Mazzoni Center in Philadelphia, Planned Parenthood, community health centers) | $0 to $100 per visit (income-based sliding scale) | Medicare-certified FQHCs bill at the FQHC encounter rate |
| Independent gender-affirming provider (Philadelphia, Pittsburgh, Harrisburg, Lehigh Valley) | $75 to $250 per visit (HRT management); $500 to $2,400 per year all-in | Approximately $185 (2026 PFS non-facility rate for a high-complexity established-patient office visit) |
| Hospital outpatient department (Penn Medicine, Jefferson, Allegheny Health Network, UPMC adult programs) | $200 to $500 per visit; surgical procedures priced separately | Hospital outpatient rate; 20% coinsurance after the $283 Part B deductible (2026) |
2026 Pennsylvania gender-affirming care costs. HRT costs reflect published telehealth pricing and FAIR Health Consumer benchmarks. Surgical ranges reflect national FAIR Health Consumer self-pay pricing and vary by surgeon, facility, and region. Medicare Part B 2026 deductible: $283; 20% coinsurance after the deductible. Pennsylvania Medical Assistance (Medicaid) covers medically necessary care for eligible adults with prior authorization through the member's HealthChoices plan. Sliding-scale fees are based on household income relative to the 2026 FPL.
Source: FAIR Health Consumer 2026, CMS Medicare Physician Fee Schedule 2026, KFF Gender-Affirming Care Policy Tracker 2026, Pennsylvania DHS Medical Assistance program
Why the Same Procedure Is So Much More at a Hospital
Pennsylvania gender-affirming care costs in 2026 depend heavily on the site of service. Telehealth platforms such as FOLX Health and Plume charge flat memberships of roughly $39 to $99 per month in 2026 that bundle clinician visits and prescription management, making them the lowest-cost entry point for hormone therapy. Federally Qualified Health Centers and community clinics, including the Mazzoni Center in Philadelphia and Planned Parenthood health centers across the state, use income-based sliding scales tied to the 2026 federal poverty level, with some visits costing $0 below 100% of FPL. Independent primary care and endocrinology practices charge $75 to $250 per visit in 2026, with labs billed separately.
Hospital-affiliated programs in Philadelphia and Pittsburgh offer multidisciplinary care, but they bill at hospital outpatient department rates that add a facility fee to the professional fee. The chargemaster price for the same hormone management visit can run 2 to 3 times higher than at an independent clinic in 2026. Pennsylvania patients who are uninsured can ask any hospital for its written self-pay discount or financial assistance policy; many hospitals reduce charges 20 to 60 percent below chargemaster list price, and some apply the reduction only when the patient asks. Hospitals that are nonprofit are required by federal tax rules to maintain a financial assistance policy.
Pennsylvania has in-state surgical capacity for adults. Penn Medicine in Philadelphia and other academic and private plastic surgery practices perform chest and genital procedures, and Pennsylvania Medical Assistance covers medically necessary surgery with prior authorization. Complex genital surgeries such as phalloplasty are concentrated at a limited number of national centers, so some patients travel; a 2026 vaginoplasty ranges from $30,000 to $45,000 and a phalloplasty from $85,000 to $135,000 at experienced U.S. centers (FAIR Health Consumer 2026). Patients under 19 in Pennsylvania face a different landscape: Penn Medicine and UPMC no longer provide surgery or youth programs, so families often rely on CHOP, other out-of-state centers, or telehealth.
Pennsylvania Gender-Affirming Care Cost by Service Type in 2026
Gender-affirming care in Pennsylvania in 2026 spans a wide cost range by service type. Hormone therapy is the most common and affordable entry point, top surgery is a mid-range one-time expense, and genital surgeries are the highest-cost procedures. The 2026 table below shows cash-pay ranges and typical coverage for adults; surgical prices are national FAIR Health Consumer benchmarks because Pennsylvania surgeons price by case.
Typical cost by variant| Service | Pennsylvania Cash-Pay Range (2026) | Typical Frequency | Coverage (Adults) |
|---|
| HRT (oral estrogen or testosterone gel) | $30 to $100 per month (medication only) | Monthly, ongoing | Covered by Medical Assistance with plan authorization; Part D covers qualifying generics |
| HRT (injectable testosterone or estrogen) | $30 to $150 per month (medication plus supplies) | Monthly to biweekly, ongoing | Covered by Medical Assistance; Part D covers injectables; Part B may cover provider-administered injections |
| HRT lab monitoring (every 3 to 6 months) | $75 to $300 per lab panel | Quarterly or semiannual | Covered by Medical Assistance; Part B covers medically necessary labs at 80% after the $283 deductible (2026) |
| Top surgery (chest masculinization) | $6,000 to $12,000 (surgeon, facility, anesthesia) | One-time procedure | Covered with prior authorization for eligible adults; Medicare case by case |
| Top surgery (breast augmentation) | $8,000 to $15,000 (surgeon, facility, anesthesia) | One-time procedure | Covered with prior authorization for eligible adults; Medicare case by case |
| Vaginoplasty | $30,000 to $45,000 | One-time procedure | Covered with prior authorization for eligible adults; 20% Medicare coinsurance if approved |
| Phalloplasty or metoidioplasty | $85,000 to $135,000 (phalloplasty); $10,000 to $20,000 (metoidioplasty) | Often staged over several procedures | Covered with prior authorization for eligible adults; may require an out-of-state center |
2026 national and Pennsylvania cash-pay pricing. HRT medication costs exclude visit and lab fees. Surgical costs include surgeon, facility, and anesthesia unless noted. Pennsylvania Medical Assistance coverage is subject to medical necessity and prior authorization by the member's plan; the 2026 federal rule limits federal funding for members under 18 (Medicaid) and under 19 (CHIP).
Source: FAIR Health Consumer 2026, KFF Gender-Affirming Care Policy Tracker 2026, Pennsylvania DHS, CMS Medicare Physician Fee Schedule 2026
What Medicare Pays for Gender-Affirming Care (Pennsylvania)
Original Medicare covers gender-affirming care for Pennsylvania beneficiaries case by case. CMS determined in 2016 that no national coverage determination applies to gender reassignment surgery (NCD 140.9), so Novitas Solutions, the Medicare Administrative Contractor for Pennsylvania (Jurisdiction L), decides individual claims. Under Medicare Part B, medically necessary surgery that is approved is paid at 80% after the 2026 Part B deductible of $283, leaving the beneficiary with 20% coinsurance. Hormone medications are generally covered under Part D when prescribed for a recognized indication. Medicare Advantage plans in Pennsylvania must cover at least what Original Medicare covers, often with prior authorization and different cost-sharing, so check the plan's Summary of Benefits. The CMS Medicare coverage database at cms.gov lists NCD 140.9.
Medigap pays the 20% coinsurance that Original Medicare leaves after approval, so a Pennsylvania beneficiary with a Medigap policy can expect little out-of-pocket cost for an approved surgery in 2026. Commercial plans in Pennsylvania vary: many large employers cover hormones and surgery, but a high-deductible health plan (HDHP) applies the full 2026 deductible first. Beginning with plan year 2026, a federal rule removed gender-affirming care from essential health benefits for ACA-compliant plan coverage sold on Pennie and off-exchange, which can mean higher cost-sharing that does not count toward the out-of-pocket maximum. A federal court in Massachusetts vacated that provision on August 14, 2026 (California v. Kennedy), though appeals may follow (KFF 2026). Prior authorization is typical for surgery on commercial and Medicare Advantage plans.
The No Surprises Act, effective January 1, 2022, gives every Pennsylvania patient who is uninsured or paying cash the right to a written Good Faith Estimate from the provider or facility before gender-affirming care. For an appointment scheduled at least 10 business days out, the Good Faith Estimate must arrive at least 3 business days before service. For an appointment scheduled 3 to 9 business days out, it must arrive at least 1 business day before. The Good Faith Estimate itemizes the surgeon fee, facility fee, anesthesia, laboratory charges, and supplies, with diagnosis and procedure codes and the provider's National Provider Identifier. Full guidance is at cms.gov/nosurprisesact and at healthcare.gov/out-of-network-bills.
To request a Good Faith Estimate for gender-affirming care in Pennsylvania in 2026, follow five steps: (1) Call the clinic, telehealth platform, or hospital and say you are self-pay or uninsured. (2) Ask for a written Good Faith Estimate listing the professional fee, facility fee, anesthesia, laboratory costs, supplies, procedure codes, and provider NPI. (3) Give your Pennsylvania ZIP code and any add-ons, such as staged surgery or lab frequency. (4) Confirm the timing: 3 business days before service if scheduled 10 or more business days out, or 1 business day if scheduled 3 to 9 business days out. (5) Keep the written Good Faith Estimate; if the final bill exceeds it by $400 or more, you have 120 days from the bill date to file a patient-provider dispute resolution claim through cms.gov/nosurprisesact.
A Good Faith Estimate for Pennsylvania gender-affirming care is not a guaranteed final bill. Common reasons actual charges exceed it include additional surgical stages or revisions, anesthesia that runs longer than projected, pathology analysis of removed tissue billed separately, recovery-room time or supplies beyond the estimate, and a separate facility fee for a pre-operative evaluation at a hospital program. Medical Assistance members should confirm that the surgeon, facility, and anesthesia group all participate in their HealthChoices plan before scheduling. If the final bill exceeds the Good Faith Estimate by $400 or more, request an itemized bill, compare it line by line, and file the dispute within 120 days if the provider will not correct it.
What Factors Affect Cost
- Pennsylvania legal and coverage status: gender-affirming care for adults is legal in Pennsylvania in 2026, and Pennsylvania Medical Assistance covers medically necessary gender dysphoria treatment through HealthChoices plans. For minors, federal pressure in 2025 and 2026 has closed several hospital programs, and the federal Medicaid rule effective October 2026 ends federal matching funds for hormones and surgery for members under 18.
- Site of service: telehealth platforms charge about $39 to $99 per month in 2026, sliding-scale clinics such as the Mazzoni Center and Planned Parenthood charge $0 to $100 per visit based on income, independent clinicians charge $75 to $250 per visit, and hospital outpatient programs can cost 2 to 3 times more because of facility fees and chargemaster pricing.
- Insurance status: Pennsylvania Medical Assistance covers eligible adults with prior authorization, Original Medicare decides case by case through Novitas Solutions, and an ACA-compliant plan on Pennie may carry higher 2026 cost-sharing because of the federal essential health benefit change, which a court vacated in August 2026. Employer plans vary, and HDHP members pay the full 2026 deductible first.
- Self-pay programs at independent and telehealth centers: independent gender-affirming clinicians and telehealth memberships often publish cash prices 30 to 60 percent below what a hospital chargemaster would bill for the same service in 2026. Asking for the cash or self-pay rate before scheduling is the most effective cost-reduction step for uninsured Pennsylvania patients.
- Hospital chargemaster discount ask: Pennsylvania hospitals publish self-pay discount and financial assistance policies, often 20 to 60 percent off chargemaster list price. Some apply the discount automatically for uninsured patients; others require an explicit request. Ask: 'What is your self-pay cash price, and is it lower than the chargemaster rate?'
- Sliding-scale FQHCs: Pennsylvania community health centers, including the Mazzoni Center in Philadelphia, and Planned Parenthood clinics offer gender-affirming hormone therapy on income-based scales tied to the 2026 FPL ($15,650 for a household of 1 in 48 states plus DC). Patients below 100% of FPL may pay $0. See the [federal poverty level](/en/federal-poverty-level) page for thresholds.
- Prior authorization and complexity: all surgery requires prior authorization on Medical Assistance, Medicare Advantage, and commercial plans, and missing authorization is the leading cause of denied claims. Top surgery costs $6,000 to $15,000 in 2026, while staged genital surgery can exceed $100,000 over several procedures.
- Federal and state policy uncertainty: the August 2026 CMS Medicaid and CHIP rule, a proposed Medicare hospital condition-of-participation rule that is not final, and Pennsylvania Senate Bill 1321 could further change youth access. Adults are not directly affected. Monitor kff.org/lgbtq/gender-affirming-care-policy-tracker/ before budgeting for surgery.
Common Gender-Affirming Care (Pennsylvania) Billing Errors
Pennsylvania gender-affirming care billing has recurring error patterns that cause denied claims or surprise bills in 2026. Knowing them before scheduling lets patients ask the right questions.
- Facility fee billed separately at hospital programs: patients often receive one bill from the physician and another from the hospital. Ask for a combined Good Faith Estimate covering both before the first appointment.
- Out-of-network anesthesia: an anesthesia group may be out-of-network even when the surgeon and facility are in-network. The No Surprises Act bars balance billing in that situation for insured patients; confirm before surgery.
- Missing prior authorization: Medical Assistance HealthChoices plans and commercial insurers deny surgical claims scheduled before written approval. Submit documentation well before the surgery date and keep the approval letter.
- Laboratory monitoring billed at hospital rates: hormone labs sent to a hospital-affiliated lab can add facility fees. Asking for an independent reference lab and a cash price in advance often saves $50 to $200 per panel in 2026.
- Diagnosis or gender-marker mismatch: claims are sometimes denied when the coded diagnosis or the sex on file does not match the procedure. Ask billing staff to verify codes with the insurer before service.
Frequently Asked Questions
How much does gender-affirming care cost without insurance in Pennsylvania in 2026?
In Pennsylvania in 2026, hormone therapy costs $30 to $200 per month for medications, or $500 to $2,400 per year all-in with labs and visits at cash prices. Telehealth memberships run about $39 to $99 per month. Top surgery costs $6,000 to $15,000, vaginoplasty $30,000 to $45,000, and phalloplasty $85,000 to $135,000 (FAIR Health Consumer 2026). Pennsylvania Medical Assistance (Medicaid) covers medically necessary care for eligible adults, which can remove most out-of-pocket cost for qualifying patients. Self-pay patients can also request a written Good Faith Estimate before treatment under the No Surprises Act.
What does Medicare pay for gender-affirming care in Pennsylvania?
Original Medicare covers gender-affirming care case by case. CMS found in 2016 that no national coverage determination applies (NCD 140.9), so Novitas Solutions, the Medicare contractor for Pennsylvania (Jurisdiction L), decides claims. For approved procedures under Medicare Part B, the beneficiary pays 20% coinsurance after the 2026 Part B deductible of $283. Hormones are generally covered by Part D. Medicare Advantage plans must cover at least what Original Medicare covers but may require prior authorization, and Medigap pays the 20% coinsurance on approved procedures.
How do I request a Good Faith Estimate for gender-affirming care in Pennsylvania?
Call the Pennsylvania provider, telehealth platform, or hospital and say you are self-pay or uninsured. Ask for a written Good Faith Estimate that itemizes surgeon, facility, anesthesia, lab, and supply charges with procedure codes and the provider NPI, and give your ZIP code and planned add-ons. The estimate is due at least 3 business days before service if scheduled 10 or more business days out, or 1 business day before if scheduled 3 to 9 business days out. Keep it: if your final bill exceeds it by $400 or more, file a dispute within 120 days at cms.gov/nosurprisesact.
What is the No Surprises Act and does it apply to gender-affirming care in Pennsylvania?
The No Surprises Act, effective January 1, 2022, protects patients from unexpected medical bills. For self-pay and uninsured patients it requires providers and facilities to give a written Good Faith Estimate before care. It applies to every Pennsylvania provider, including clinics, telehealth platforms, and hospitals, whether or not the service is covered by insurance. It also bars surprise balance billing when an out-of-network clinician, such as an anesthesiologist, treats you at an in-network facility. Medicare and Medicaid have separate protections. Full guidance is at cms.gov/nosurprisesact.
How do I get a written cash-pay quote for gender-affirming care in Pennsylvania?
Ask the provider: 'What is your self-pay or cash price for this service?' Many telehealth platforms publish prices online. For in-person clinics, request the price in writing before the first visit, ideally as a Good Faith Estimate. At hospital programs, ask whether a self-pay discount exists and what percentage off chargemaster it provides; Pennsylvania hospitals often take 20 to 60 percent off, and some apply it only on request. Confirm the quote includes professional, facility, anesthesia, and lab charges, and ask about a prepayment discount.
Can I negotiate a gender-affirming care bill in Pennsylvania after the fact?
Yes. Contact the billing office, request an itemized bill, and compare it to any Good Faith Estimate. Ask hospital billing for its financial assistance or charity care application. If the bill exceeds your Good Faith Estimate by $400 or more, file a patient-provider dispute resolution claim within 120 days of the bill date at cms.gov/nosurprisesact. For cash-pay bills, offering to pay in full within 30 days often earns a 20 to 40 percent reduction, and the 2026 federal poverty level helps determine eligibility for charity care.
What is the difference between hospital and independent or telehealth gender-affirming care cost in Pennsylvania?
Hospital programs in Philadelphia and Pittsburgh offer multidisciplinary care under one roof but bill at hospital outpatient rates that add a facility fee to the professional fee. In 2026 a hormone management visit with chargemaster pricing can run $200 to $500, while an independent clinic charges $75 to $250 and a telehealth membership runs about $39 to $99 per month. For patients with stable hormone needs, independent and telehealth care delivers similar clinical care at 2 to 3 times lower cost, while complex surgical planning may still warrant a hospital program.
Will Pennsylvania Medical Assistance or my ACA plan cover gender-affirming care in 2026?
Gender-affirming care is not a USPSTF preventive service, so normal deductibles and cost-sharing apply. Pennsylvania Medical Assistance (Medicaid) explicitly covers medically necessary gender dysphoria treatment, including hormones, labs, and surgery, with prior authorization from the member's HealthChoices plan. For an ACA-compliant plan on Pennie, a federal rule removed these services from essential health benefits for plan year 2026, but a federal court vacated that provision on August 14, 2026, so check your plan's Summary of Benefits. Coverage for members under 18 faces new federal Medicaid funding limits effective October 2026.
What is the difference between hormone therapy and surgery costs for gender-affirming care in Pennsylvania?
Hormone therapy is an ongoing cost: $30 to $200 per month for medications plus $75 to $300 per lab panel, about $500 to $2,400 per year for self-pay patients in 2026. Surgery is a one-time major expense: top surgery $6,000 to $15,000, vaginoplasty $30,000 to $45,000, and phalloplasty $85,000 to $135,000 (FAIR Health Consumer 2026). Pennsylvania Medical Assistance covers both for eligible adults, but surgery needs prior authorization that can take weeks. Hormones are manageable monthly, while surgery usually requires savings, insurance approval, or a financing plan.
Is gender-affirming care legal in Pennsylvania for adults and minors in 2026?
Gender-affirming care is legal in Pennsylvania for adults and, under state law, for minors; Pennsylvania has no ban. Access for patients under 19 has narrowed in practice: Penn Medicine ended surgery for patients under 19 in May 2025, and UPMC ended youth programs in June 2025 and agreed in September 2026 to a federal settlement ending such care for a decade. CHOP has continued its program. A federal Medicaid and CHIP rule effective October 2026 ends federal matching funds for minors, and Senate Bill 1321 would extend that to state funds but was not law as of October 2026.
